Use the links below to see how different research questions can be answered in Causaly.
A. Drug-centric search
- Diseases treated by adalimumab (Intelligent Search)
- Effects of adalimumab in rheumatoid arthritis coming from clinical trials (Intelligent Search)
- Side effects of adalimumab (Intelligent Search)
- Side effects of adalimumab in patients that have rheumatoid arthritis (Intelligent Search)
- Side effects of PD-L1 inhibitors (Intelligent Search)
- Side effects of nivolumab on the respiratory system (Intelligent Search)
- Potential mediators by which nivolumab may affect pneumonia (Multihop)
- Common side effects of trastuzumab and docetaxel (Advanced→ delta analysis)
- Mechanisms causing PD-L1 inhibitor resistance (Intelligence Search)
- Drug-drug interaction between cimetidine and warfarin (Intelligent Search)
- Effects of omalizumab on IgE related biochemical pathways (Intelligent Search)
- Cosentyx MoA (Intelligent Search)
B. Target (gene/protein)-centric search
- Diseases associated with BCL-2 gene (Intelligent Search)
- Side effects caused by the inhibition of BCL2 (Intelligent Search)
- Pathways affected by PD-L1 in breast cancer (Intelligent Search)
- Immunohistochemistry data for the factors affecting BCL-2 expression (Intelligent Search)
- Association of BCL-2 and PTEN genes (Intelligent Search)
- Diseases regulated by BCL-2 and PTEN genes (Advanced→ delta analysis)
- Potential druggable targets implicated in tumor microenvironment (Multihop)
- Mediators of NSCLC regulation by PD-L1 (Multihop)
- Proteins related to immune suppression and leukemia (Multihop)
- Prevalence and incidence of the BRCA1 mutation in breast cancer patients (Epidemiology)
- Neuronal biochemical pathways affected by amyloid beta (Intelligent Search)
- Diseases affected by tp53 mutations (Intelligent Search)
C. Disease-centric search
- Treatments of asthma (Intelligent Search)
- Treatments for breast cancer in patients with BRCA1 mutation (Intelligent Search)
- Biomarkers of Lupus Erythematosus (Intelligent Search)
- Biomarkers of hypertensive disease for obese patients (Intelligent Search)
- Common and unique biomarkers for rheumatoid arthritis and lupus erythematosus systemic (Advanced→ delta analysis)
- Comorbidities of Lupus Erythematosus (Intelligent Search)
- Mediators of NSCLC regulation by PD-L1 (Multihop)
- Treatments of COVID-19 in COPD patients (Intelligent Search)
- Proteins related to immune suppression and leukemia (Multihop)
- Prevalence and incidence of Lupus Systemic Erythematosus (Epidemiology)
- Prevalence and incidence of pediatric psoriasis (Epidemiology)
- Prevalence of Alzheimer’s disease in China and Japan (Epidemiology)
- Prevalence and incidence of liver cirrhosis in patients with NAFLD (Epidemiology)
- Factors affecting treatment response in patients with IBD undergoing anti-TNF therapy (Intelligent Search)
- Biomarkers of disease progression in patients with multiple sclerosis (Intelligent Search)
- Biomarkers of pembrolizumab response in patients with cancer (Intelligent Search)